Copyright
©The Author(s) 2022.
World J Gastrointest Endosc. Jun 16, 2022; 14(6): 387-401
Published online Jun 16, 2022. doi: 10.4253/wjge.v14.i6.387
Published online Jun 16, 2022. doi: 10.4253/wjge.v14.i6.387
Total | Colon operations | Rectal operations | P value | ||
n | 214 | 133 | 81 | ||
Sex | Male | 128 (59.8%) | 78 (58.6%) | 50 (61.7%) | NS |
Female | 86 (40.2%) | 55 (41.4%) | 31 (38.3%) | ||
Age (yr) | 70 (13) | 71 (14) | 68 (13) | NS | |
BMI (kg/m2) | 27 (5) | 28 (5) | 26.5 (4) | NS | |
ASA score | I | 71 (33.2%) | 35 (26.3%) | 36 (44.4%) | 0.021 |
II | 117 (54.7%) | 79 (59.4%) | 38 (46.9%) | ||
III | 26 (12.1%) | 19 (14.3%) | 7 (8.6%) | ||
Diagnosis | Malignancy | 206 (96.3%) | 125 (94%) | 81 (100%) | NS |
Diverticulitis | 6 (2.8%) | 6 (4.5%) | 0 (0%) | ||
Volvulus | 1 (0.5%) | 1 (0.8%) | 0 (0%) | ||
Crohn’s disease | 1 (0.5%) | 1 (0.8%) | 0 (0%) | ||
Previous operation | 17 (7.9%) | 13 (9.8%) | 4 (4.9%) | NS | |
T | 1 | 51 (24.8%) | 33 (26.4%) | 18 (22.2%) | NS |
2 | 63 (30.6%) | 39 (31.2%) | 24 (29.6%) | ||
3 | 85 (41.3%) | 47 (37.6%) | 38 (46.9%) | ||
4 | 7 (3.4%) | 6 (4.8%) | 1 (1.2%) | ||
N | 0 | 153 (74.3%) | 89 (71.2%) | 64 (79%) | NS |
1 | 42 (20.4%) | 30 (24%) | 12 (14.8%) | ||
2 | 11 (5.3%) | 6 (4.8%) | 5 (6.2%) | ||
M | 0 | 205 (99.5%) | 125 (100%) | 80 (98.8%) | NS |
1 | 1 (0.5%) | 0 (0%) | 1 (1.2%) | ||
Neoadjuvant modality | 19 (9.2%) | 2 (1.6%) | 17 (20%) | < 0.001 | |
Complexity level | 1 | 116 (54.2%) | 74 (55.6%) | 42 (51.9%) | 0.022 |
2 | 82 (38.2%) | 44 (33.1%) | 38 (46.9%) | ||
3 | 6 (2.8%) | 6 (4.5%) | 0 (0%) | ||
4 | 10 (4.7%) | 9 (6.8%) | 1 (1.2%) | ||
Operation | Right colectomy | 76 (35.5%) | 76 (57.1%) | - | < 0.001 |
Left colectomy | 31 (14.5%) | 31 (23.3%) | - | ||
Sigmoidectomy | 26 (12.1%) | 26 (19.5%) | - | ||
Low anterior resection | 72 (33.6%) | - | 72 (88.9%) | ||
Ultra-low anterior resection | 7 (3.3%) | - | 7 (8.6%) | ||
Abdominoperineal resection | 2 (1%) | - | 2 (2.4%) | ||
Emergency status | Elective | 212 (99.1%) | 131 (98.5%) | 81 (100%) | NS |
Semi-elective | 2 (0.9%) | 2 (1.5%) | 0 (0%) | ||
Laparoscopic approach | Totally laparoscopic | 182 (85%) | 127 (95.5%) | 55 (67.9%) | < 0.001 |
Laparoscopy assisted | 32 (15%) | 6 (4.5%) | 26 (32.1%) | ||
Preoperative optimization | Bowel preparation | 191 (89.3%) | 112 (84.2%) | 79 (97.5%) | 0.002 |
Antibiotic preparation | 206 (96.3%) | 127 (95.5%) | 79 (97.5%) | NS | |
Tattoo | 51 (23.8%) | 28 (21.1%) | 23 (28.4%) | NS | |
Extraction site | Pfannenstiel | 95 (44.4%) | 40 (30.1%) | 55 (67.9%) | < 0.001 |
Subumbilical | 19 (8.9%) | 4 (3%) | 15 (18.5%) | ||
Transumbilical | 100 (46.7%) | 89 (66.9%) | 11 (13.6%) | ||
Anastomosis | Stapled | 159 (75%) | 80 (60.2%) | 79 (100%) | < 0.001 |
Handsewn | 53 (25%) | 53 (39.8%) | 0 (0%) | ||
Intracorporeal | 112 (52.8%) | 50 (37.6%) | 62 (78.4%) | < 0.001 | |
Extracorporeal | 100 (47.1%) | 83 (62.4%) | 17 (21.5%) | ||
Protective stoma | 66 (30.8%) | 9 (6.8%) | 57 (70.4%) | < 0.001 | |
Operation duration (min) | 180 (51) | 180 (50) | 200 (60) | < 0.001 | |
Open conversion | 20 (9.3%) | 6 (4.5%) | 14 (17.3%) | 0.002 | |
Transfusion | 8 (3.7%) | 4 (3%) | 4 (4.9%) | NS | |
Tumor diameter (cm) | 3 (2.2) | 3 (2) | 3.75 (2.5) | NS | |
Specimen length (cm) | 20 (9) | 21 (7) | 15 (7) | < 0.001 | |
Distal margin (cm) | 5 (4.35) | 5.25 (3.5) | 4.5 (4.25) | 0.01 | |
Lymph nodes | 17 (12) | 19 (13) | 15 (11) | 0.004 | |
Lymph node ratio | 0 (2.3) | 0 (4) | 0 (0) | NS | |
Histological grade | 1 | 40 (19.4%) | 20 (16%) | 20 (24.7%) | NS |
2 | 135 (65.5%) | 89 (71.2%) | 46 (56.8%) | ||
3 | 31 (15%) | 16 (12.8%) | 15 (18.5%) | ||
R status | 0 | 204 (95.3%) | 124 (99.2%) | 80 (98.8%) | NS |
1 | 2 (0.9%) | 1 (0.8%) | 1 (1.2%) | ||
Resection plane | Mesocolic/mesorectal | 183 (88.8%) | 108 (86.4%) | 75 (88.8%) | NS |
Intramesocolic/intramesorectal | 19 (9.2%) | 14 (11.2%) | 5 (6.2%) | ||
Muscularis propria | 4 (1.9%) | 3 (2.4%) | 1 (1.2%) | ||
Extramural vascular invasion | 54 (26.2%) | 33 (26.4%) | 21 (25.9%) | NS | |
Perineural invasion | 21 (10.2%) | 13 (10.4%) | 8 (9.9%) | NS | |
Mucous | Focal | 29 (14.1%) | 20 (16%) | 9 (11.1%) | NS |
Diffuse | 20 (9.7%) | 15 (12%) | 5 (6.2%) | ||
Complications | Total | 49 (22.9%) | 33 (24.8%) | 16 (19.8%) | NS |
Wound infection | 9 (4.2%) | 5 (3.8%) | 4 (4.9%) | NS | |
Wound dehiscence | 2 (0.9%) | 2 (1.5%) | 0 (0%) | ||
Leak | 14 (6.5%) | 10 (7.5%) | 4 (4.9%) | ||
Postoperative ileus | 11 (5.1%) | 8 (6%) | 3 (3.7%) | ||
Urinary tract infection | 2 (0.9%) | 0 (0%) | 2 (2.5%) | ||
Urinary retention | 2 (0.9%) | 1 (0.8%) | 1 (1.2%) | ||
Bleeding | 3 (1.4%) | 1 (0.8%) | 2 (2.5%) | ||
Pulmonary embolism | 2 (0.9%) | 2 (1.5%) | 0 (0%) | ||
ARDS | 1 (0.5%) | 0 (0%) | 1 (1.2%) | ||
Other | 4 (1.9%) | 4 (3%) | 0 (0%) | ||
Relaparotomy | 11 (5.1%) | 8 (6%) | 3 (3.7%) | NS | |
ICU | 8 (3.7%) | 5 (3.8%) | 3 (3.7%) | NS | |
Mortality | 5 (2.3%) | 4 (3%) | 1 (1.2%) | NS | |
Length of hospital stay (d) | 6 (2) | 6 (2) | 6 (2) | NS | |
Follow-up (mo) | 2 (3.75) | 2 (5.8) | 2 (2.5) | NS |
Overall | Colon | Rectal | ||||||||||
Phase I (1-109) | Phase II (110-144) | Phase III (145-214) | P value | Phase I (1-57) | Phase II (58-133) | P value | Phase I (1-51) | Phase II (52-81) | P value | |||
N | 109 | 35 | 70 | 57 | 76 | 51 | 30 | |||||
Sex | Male | 68 (62.4%) | 24 (68.6%) | 36 (51.4%) | NS | 37 (64.9%) | 41 (53.9%) | NS | 30 (58.8%) | 20 (66.7%) | NS | |
Female | 41 (37.6%) | 11 (31.4%) | 34 (48.6%) | 20 (35.1%) | 35 (46.1%) | 21 (41.2%) | 10 (33.3%) | |||||
Age (yr) | 71.5 (12) | 70 (13) | 69.5 (14) | NS | 72 (14) | 71 (13) | NS | 69.5 (12) | 67 (16) | NS | ||
BMI (kg/m2) | 27 (5) | 28 (4) | 27 (5) | NS | 28 (6) | 28 (5) | NS | 26 (3) | 27.5 (6) | NS | ||
ASA score | I | 36 (33%) | 13 (37.1%) | 22 (31.4%) | NS | 14 (24.6%) | 21 (27.6%) | NS | 21 (41.2%) | 15 (50%) | NS | |
II | 62 (56.9%) | 16 (45.7%) | 39 (55.7%) | 35 (61.4%) | 44 (57.9%) | 27 (52.9%) | 11 (36.7%) | |||||
III | 11 (10.1%) | 6 (17.1%) | 9 (12.9%) | 8 (14%) | 11 (14.5%) | 3 (5.9%) | 4 (13.3%) | |||||
Diagnosis | Malignancy | 106 (97.2%) | 34 (97.1%) | 66 (94.3%) | NS | 54 (94.7%) | 71 (93.4%) | NS | 51 (100%) | 30 (100%) | - | |
Diverticulitis | 2 (1.8%) | 1 (2.9%) | 3 (4.3%) | 2 (3.5%) | 4 (5.3%) | - | - | |||||
Volvulus | 1 (0.9%) | 0 (0%) | 0 (0%) | 1 (1.8%) | 0 (0%) | - | - | |||||
Crohn’s disease | 0 (0%) | 0 (0%) | 1 (1.4%) | 0 (0%) | 1 (1.3%) | - | - | |||||
Previous operation | 13 (11.9%) | 2 (5.7%) | 2 (2.9%) | NS | 9 (15.8%) | 4 (5.3%) | 0.04 | 4 (7.8%) | 0 (0%) | NS | ||
T | 1 | 24 (22.6%) | 6 (17.6%) | 21 (31.8%) | NS | 12 (22.6%) | 21 (29.2%) | NS | 12 (23.5%) | 6 (20%) | NS | |
2 | 34 (32.1%) | 7 ( (20.6%) | 22 (33.3%) | 16 (30.2%) | 23 (31.9%) | 18 (35.3%) | 6 (20%) | |||||
3 | 43 (40.6%) | 20 (58.8%) | 22 (33.3%) | 21 (39.6%) | 26 (36.1%) | 20 (39.2%) | 18 (60%) | |||||
4 | 5 (4.7%) | 1 (2.9%) | 1 (1.5%) | 4 (7.5%) | 2 (2.8%) | 1 (2%) | 0 (0%) | |||||
N | 0 | 77 (74.5%) | 25 (73.5%) | 49 (74.2%) | NS | 36 (67.9%) | 53 (73.6%) | NS | 41 (80.4%) | 23 (76.7%) | NS | |
1 | 23 (21.7%) | 6 (17.6%) | 13 (19.7%) | 16 (30.2%) | 14 (19.4%) | 6 (13.7%) | 5 (16.7%) | |||||
2 | 4 (3.8%) | 3 (8.8%) | 4 (6.1%) | 1 (1.9%) | 5 (6.9%) | 3 (5.9%) | 2 (6.7%) | |||||
M | 0 | 106 (100%) | 34 (100%) | 65 (98.5%) | NS | 53 (100%) | 72 (100%) | - | 51 (100%) | 29 (96.7%) | NS | |
1 | 0 (0%) | 0 (0%) | 1 (1.5%) | - | - | 0 (0%) | 1 (3.3%) | |||||
Neoadjuvant modality | 6 (5.5%) | 5 (14.3%) | 8 (11.4%) | NS | 0 (0%) | 2 (2.6%) | NS | 6 (11.8%) | 11 (36.7%) | 0.008 | ||
Complexity level | 1 | 50 (54.1%) | 13 (37.1%) | 44 (62.9%) | NS | 29 (50.9%) | 45 (59.2%) | NS | 30 (58.8%) | 12 (40%) | NS | |
2 | 42 (38.5%) | 20 (57.1%) | 20 (28.6%) | 21 (36.8%) | 23 (30.3%) | 20 (39.2%) | 18 (60%) | |||||
3 | 2 (1.8%) | 1 (2.9%) | 3 (4.3%) | 2 (3.5%) | 4 (5.3%) | 0 (0%) | 0 (0%) | |||||
4 | 6 (5.5%) | 1 (2.9%) | 3 (4.3%) | 5 (8.8%) | 4 (5.3%) | 1 (2%) | 0 (0%) | |||||
Operation | Right colectomy | 34 (31.2%) | 13 (37.1%) | 29 (41.4%) | NS | 34 (59.6%) | 42 (55.3%) | NS | - | - | NS | |
Left colectomy | 10 (9.2%) | 6 (17.1%) | 15 (21.4%) | 10 (17.5%) | 21 (27.6%) | - | - | |||||
Sigmoidectomy | 13 (11.9%) | 2 (5.7%) | 11 (15.7%) | 13 (22.8%) | 13 (17.1%) | - | - | |||||
Low anterior resection | 46 (42.2%) | 13 (37.1%) | 13 (18.6%) | - | - | 45 (88.2%) | 27 (90%) | |||||
Ultra-low anterior resection | 4 (3.7%) | 1 (2.9%) | 2 (2.9%) | - | - | 4 (7.8%) | 3 (10%) | |||||
Abdominoperineal resection | 2 (1.8%) | 0 (0%) | 0 (0%) | - | - | 2 (4%) | 0 (0%) | |||||
Emergency status | Elective | 109 (100%) | 35 (100%) | 68 (97.1%) | NS | 57 (100%) | 74 (97.4%) | NS | 51 (100%) | 30 (100%) | - | |
Semi-elective | 0 (0%) | 0 (0%) | 2 (2.9%) | 0 (0%) | 2 (2.6%) | - | - | |||||
Laparoscopic approach | Totally laparoscopic | 98 (89.9%) | 24 (68.6%) | 60 (85.7%) | 0.009 | 56 (98.2%) | 71 (93.4%) | NS | 41 (80.4%) | 14 (46.7%) | 0.002 | |
Laparoscopy assisted | 11 (10.1%) | 11 (31.4%) | 10 (14.3%) | 1 (1.8%) | 5 (6.6%) | 10 (19.6%) | 16 (53.3%) | |||||
Preoperative optimization | Bowel preparation | 107 (98.2%) | 30 (85.7%) | 54 (77.1%) | < 0.001 | 56 (98.2%) | 56 (73.7%) | < 0.001 | 50 (98%) | 29 (96.7%) | NS | |
Antibiotic preparation | 105 (96.3%) | 33 (94.3%) | 68 (97.1%) | NS | 54 (94.7%) | 73 (96.1%) | NS | 50 (98%) | 29 (96.7%) | NS | ||
Tattoo | 36 (33%) | 2 (5.7%) | 13 (18.6%) | 0.002 | 17 (29.8%) | 11 (14.5%) | 0.032 | 19 (37.3%) | 4 (13.3%) | 0.021 | ||
Extraction site | Pfannenstiel | 52 (47.7%) | 15 (42.9%) | 28 (40%) | NS | 15 (26.3%) | 25 (32.9%) | NS | 37 (72.5) | 18 (60%) | NS | |
Subumbilical | 12 (11%) | 4 (11.4%) | 3 (4.3%) | 2 (3.5%) | 2 (2.6%) | 9 (17.6%) | 6 (20%) | |||||
Transumbilical | 45 (41.3%) | 16 (45.7%) | 39 (55.7%) | 40 (70.2%) | 49 (64.5%) | 5 (9.8%) | 6 (20%) | |||||
Anastomosis | Stapled | 85 (78.7%) | 24 (70.6%) | 50 (71.4%) | NS | 34 (59.6%) | 46 (60.5%) | NS | 50 (100%) | 29 (100%) | NS | |
Handsewn | 23 (21.3%) | 10 (29.4%) | 20 (28.6%) | 23 (40.4%) | 30 (39.5%) | 0 (0%) | 0 (0%) | |||||
Intracorporeal | 57 (52.8%) | 16 (47.1%) | 39 (55.7%) | NS | 18 (31.6%) | 32 (42.1%) | NS | 38 (76%) | 24 (82.8%) | NS | ||
Extracorporeal | 51 (47.2%) | 18 (52.9%) | 31 (44.3%) | 39 (68.4%) | 44 (57.9%) | 12 (24%) | 5 (17.2%) | |||||
Protective stoma | 38 (34.9%) | 11 (31.4%) | 17 (24.3%) | NS | 3 (5.3%) | 6 (7.9%) | NS | 34 (66.7%) | 23 (76.7%) | NS | ||
Operation duration (min) | 180 (50) | 220 (60) | 180 (40) | < 0.001 | 160 (48) | 180 (40) | 0.003 | 200 (50) | 220 (63) | 0.003 | ||
Open conversion | 13 (11.9%) | 2 (5.7%) | 5 (7.1%) | NS | 4 (7%) | 2 (2.6%) | NS | 8 (15.7%) | 6 (20%) | NS | ||
Transfusion | 5 (4.6%) | 0 (0%) | 3 (4.3%) | NS | 3 (5.3%) | 1 (1.3%) | NS | 1 (2%) | 3 (10%) | NS | ||
Tumor diameter (cm) | 3 (2.1) | 4 (2.4) | 3 (2) | NS | 3 (1.5) | 3.5 (2) | NS | 4 (2.4) | 3 (3) | NS | ||
Specimen length (cm) | 16.25 (7.25) | 22.5 (6.5) | 24 (8) | < 0.001 | 20.5 (8) | 23 (8.75) | 0.001 | 14.25 (3.75) | 21 (6) | < 0.001 | ||
Distal margin (cm) | 4 (3.5) | 7 (2) | 7 (5) | < 0.001 | 4 (2.5) | 7 (3.5) | < 0.001 | 4 (4.25) | 5 (4.5) | NS | ||
Lymph nodes | 15 (10) | 20 (19) | 21 (12) | 0.016 | 15 (10) | 22 (13) | 0.002 | 15 (10) | 12.5 (15) | NS | ||
Lymph node ratio | 0 (0) | 0 (0.8) | 0 (8) | NS | 0 (4.5) | 0 (3.8) | NS | 0 (0) | 0 (13.5) | NS | ||
Histological grade | 1 | 26 (24.5%) | 1 (2.9%) | 13 (19.7%) | 0.013 | 10 (18.9%) | 10 (13.9%) | 0.009 | 16 (31.4%) | 4 (13.3%) | NS | |
2 | 60 (56.6%) | 27 (79.5%) | 48 (72.7%) | 31 (58.5%) | 58 (80.6%) | 27 (52.9%) | 19 (63.3%) | |||||
3 | 20 (18.9%) | 6 (17.6%) | 5 (7.6%) | 12 (22.6%) | 4 (5.6%) | 8 (15.7%)_ | 7 (23.3%) | |||||
R status | 0 | 105 (99.1%) | 33 (97.1%) | 66 (100%) | NS | 53 (98.1%) | 71 (100%) | NS | 51 (100%) | 29 (96.7%) | NS | |
1 | 1 (0.9%) | 1 (2.9%) | 0 (0%) | 1 (1.9%) | 0 (0%) | 0 (0%) | 1 (3.3%) | |||||
Resection plane | Mesocoli/mesorectal | 91 (85.8%) | 31 (91.2%) | 61 (92.4%) | NS | 43 (79.6%) | 65 (91.5%) | NS | 47 (92.2%) | 28 (93.3%) | NS | |
Intramesocolic/intramesorectal | 12 (11.3%) | 3 (8.8%) | 4 (6.1%) | 9 (16.7%) | 5 (7%) | 3 (5.9%) | 2 (6.7%) | |||||
Muscularis propria | 3 (2.8%) | 0 (0%) | 1 (1.5%) | 2 (3.7%) | 1 (1.4%) | 1 (2%) | 0 (0%) | |||||
Extramural vascular invasion | 30 (28.3%) | 7 (20.6%) | 17 (25.8%) | NS | 13 (24.5%) | 20 (27.8%) | NS | 16 (31.4%) | 5 (16.7%) | NS | ||
Perineural invasion | 13 (12.3%) | 4 (11.8%) | 4 (6.1%) | NS | 7 (13.2%) | 6 (8.3%) | NS | 6 (11.8%) | 2 (6.7%) | NS | ||
Mucous | Focal | 11 (10.4%) | 12 (35.3%) | 6 (9.1%) | 0.006 | 6 (11.3%) | 14 (19.4%) | NS | 4 (7.8%) | 5 (16.7%) | NS | |
Diffuse | 9 (8.5%) | 3 (8.8%) | 8 (12.1%) | 7 (13.2%) | 8 (11.1%) | 2 (3.9%) | 3 (10%) | |||||
Complications | Total | 28 (25.7%) | 9 (25.7%) | 12 (17.1%) | NS | 15 (26.3%) | 18 (23.7%) | NS | 12 (23.5%) | 4 (13.3%) | NS | |
Wound infection | 5 (4.6%) | 2 (5.7%) | 2 (2.9%) | NS | 1 (1.8%) | 4 (5.3%) | NS | 4 (7.8%) | 0 (0%) | NS | ||
Wound dehiscence | 1 (0.9%) | 1 (2.9%) | 0 (0%) | 1 (1.8%) | 1 (1.3%) | 0 (0%) | 0 (0%) | |||||
Leak | 8 (7.3%) | 4 (11.4%) | 2 (2.9%) | 5 (8.8%) | 5 (6.6%) | 2 (3.9%) | 2 (6.7%) | |||||
Postoperative ileus | 7 (6.4%) | 1 (2.9%) | 3 (4.3%) | 4 (7%) | 4 (5.3%) | 3 (5.9%) | 0 (0%) | |||||
Urinary tract infection | 2 (1.8%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (3.9%) | 0 (0%) | |||||
Urinary retention | 1 (0.9%) | 0 (0%) | 1 (1.4%) | 0 (0%) | 1 (1.3%) | 1 (2%) | 0 (0%) | |||||
Bleeding | 1 (0.9%) | 0 (0%) | 2 (2.9%) | 0 (0%) | 1 (1.3%) | 1 (2%) | 1 (3.3%) | |||||
Pulmonary embolism | 1 (0.9%) | 1 (2.9%) | 0 (0%) | 1 (1.8%) | 1 (1.3%) | 0 (0%) | 0 (0%) | |||||
ARDS | 0 (0%) | 0 (0%) | 1 (1.4%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (3.3%) | |||||
Other | 3 (2.8%) | 0 (0%) | 1 (1.4%) | 3 (5.3%) | 1 (1.3%) | 0 (0%) | 0 (0%) | |||||
Relaparotomy | 5 (4.6%) | 3 (8.6%) | 3 (4.3%) | NS | 2 (3.5%) | 6 (7.9%) | NS | 2 (3.9%) | 1 (3.3%) | NS | ||
ICU | 6 (5.5%) | 1 (2.9%) | 1 (1.4%) | NS | 4 (7%) | 1 (1.3%) | NS | 2 (3.9%) | 1 (3.3%) | NS | ||
Mortality | 4 (3.7%) | 1 (2.9%) | 0 (0%) | NS | 3 (5.3%) | 1 (1.3%) | NS | 1 (2%) | 0 (0%) | NS | ||
Length of hospital stay (d) | 6 (2) | 6 (3) | 6 (2) | NS | 6 (2) | 6 (2) | NS | 6 (2) | 5 (1) | NS | ||
Follow-up (mo) | 2 (3.25) | 0.65 (0) | 6 (5) | NS | 2 (3.3) | 6.8 (4.4) | NS | 2 (3) | 0.27 (0) | 0.032 |
- Citation: Perivoliotis K, Baloyiannis I, Mamaloudis I, Volakakis G, Valaroutsos A, Tzovaras G. Change point analysis validation of the learning curve in laparoscopic colorectal surgery: Experience from a non-structured training setting. World J Gastrointest Endosc 2022; 14(6): 387-401
- URL: https://www.wjgnet.com/1948-5190/full/v14/i6/387.htm
- DOI: https://dx.doi.org/10.4253/wjge.v14.i6.387